Supernus Pharmaceuticals Holds Special Stockholder Meeting
Supernus Pharmaceuticals shareholders adopted the merger agreement with Indivior at a special meeting on October 15, 2026. Under the agreement, Artemis Merger Sub would merge into Supernus, leaving Supernus as a wholly owned subsidiary of Indivior. Disclaimer: This news brief was created by Public Technologies (PUBT) u